Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 28Burkitt Lymphoma 20Leukemia, Myeloid, Acute 11Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 7Myeloproliferative Disorders 5Myelodysplastic Syndromes 5Lymphoma, Non-Hodgkin 5Lymphoma, Mantle-Cell 5Lymphoma, Large B-Cell, Diffuse 5Leukemia, Myelomonocytic, Chronic 5Leukemia, Myeloid, Accelerated Phase 5Leukemia, Lymphocytic, Chronic, B-Cell 5Leukemia, Biphenotypic, Acute 5Hodgkin Disease 5Congenital Abnormalities 5Lymphoma, Large-Cell, Anaplastic 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Blast Crisis 4Anemia, Refractory, with Excess of Blasts 4Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Follicular 3Lymphoma, B-Cell, Marginal Zone 3Lymphoma 3Hematologic Neoplasms 3Chromosome 5q Deletion Syndrome 3Breast Neoplasms 3Waldenstrom Macroglobulinemia 2Sezary Syndrome 2Recurrence 2Primary Myelofibrosis 2

Interventions

Rituximab 5Valganciclovir 2Methotrexate 2Leucovorin 2Doxorubicin 2valomaciclovir 1threonic acid 1pembrolizumab 1otelixizumab 1merphos 1cc-486 1avelumab 1Zidovudine 1Vincristine 1Valacyclovir 1Tomography, X-Ray Computed 1Prednisone 1Magnesium Sulfate 1Interferons 1Hydroxyurea 1Etoposide 1Echocardiography 1EPOCH protocol 1Cyclophosphamide 1Caves 1Carboplatin 1Brentuximab Vedotin 1Bortezomib 1Azacitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Epstein-Barr Virus Infections × merphos × Clear all
NCT01964755 2019-09-23

Chemotherapy for Relapsed Epstein Barr Virus Associated Lymphoma

University of Miami

Phase 2 Terminated
6 enrolled 14 charts
Lymphoid

Hodgkin Disease, Lymphoma, Non-Hodgkin, Epstein-Barr Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡